The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study
Introduction Medicines acting on the central nervous system can increase the risk of postoperative delirium, but the specific medicines associated with greatest risk remain unclear. Objectives We aimed to examine the risk of individual central nervous system-acting medicines used preoperatively on d...
Gespeichert in:
Veröffentlicht in: | Drug safety 2022, Vol.45 (1), p.75-82 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 82 |
---|---|
container_issue | 1 |
container_start_page | 75 |
container_title | Drug safety |
container_volume | 45 |
creator | Kassie, Gizat M. Roughead, Elizabeth E. Nguyen, Tuan A. Pratt, Nicole L. Kalisch Ellett, Lisa M. |
description | Introduction
Medicines acting on the central nervous system can increase the risk of postoperative delirium, but the specific medicines associated with greatest risk remain unclear.
Objectives
We aimed to examine the risk of individual central nervous system-acting medicines used preoperatively on delirium after hip or knee surgery.
Methods
A matched case-control study was conducted using data from the Australian Government Department of Veterans’ Affairs. We included people aged 65 years or older who had knee or hip surgery between 2000 and 2019. People with hip or knee surgery who developed postoperative delirium were cases and controls were people with hip or knee surgery but who did not develop postoperative delirium. Use of medicines including anxiolytics, sedatives, and hypnotics, opioid analgesics and antidepressants prior to surgery was compared between cases and controls.
Results
A total of 2614 patient cases with postoperative delirium were matched by same sex, age (±2 years), and year of admission (±2 years) with 7842 controls without postoperative delirium. Cases were more likely to be exposed to nitrazepam (odds ratio [OR] = 1.81, 95% confidence interval [CI] 1.24–2.64), sertraline (OR = 1.50, 95% CI 1.20–1.87), mirtazapine (OR = 1.38, 95% CI 1.11–1.74), venlafaxine (OR = 1.42, 95% CI 1.02–1.98), citalopram (OR = 1.54, 95% CI 1.19–1.99), escitalopram (OR = 1.42, 95% CI 1.06–1.89) or fluvoxamine (OR = 5.01, 95% CI 2.15–11.68) prior to surgery than controls. At the class level, exposure to benzodiazepines (OR = 1.20, 95% CI 1.05–1.37) and antidepressants (OR = 1.64, 95% CI 1.47–1.83) prior to surgery was significantly higher in cases than in controls. The numbers needed to treat to harm for one additional delirium case were 43 for sertraline, 40 for citalopram, 57 for mirtazapine and 26 for nitrazepam. Whereas, the numbers needed to treat to harm were found to be 20 for sertraline, 17 for citalopram, 19 for mirtazapine and 10 for nitrazepam in the 85 years or older age group, indicating that the harmful effect of these medicines is pronounced as age advances.
Conclusions
People who developed delirium following hip or knee surgery were more likely to be exposed to nitrazepam, sertraline, mirtazapine, venlafaxine, citalopram, escitalopram or fluvoxamine at the time of admission for surgery. Planning to reduce use of these medicines well prior to surgery may decrease the risk of postoperative delirium. |
doi_str_mv | 10.1007/s40264-021-01136-1 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2622303805</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2622303805</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-f24b72fef9689ab45bcc6f052cee4e06f24d1e0fe88145f0a70434902556dd5f3</originalsourceid><addsrcrecordid>eNp9kMFO3DAQhq2qqGwpL9BDNVLPbseO7STcVgFKBRTUhbOVTcYQmo0XO6HaV-hTY7oUbj2NNPPN_0sfYx8FfhGI-deoUBrFUQqOQmSGizdsJkReclEq-ZbN0lZxXQqzy97HeIeIhTTFO7abqVwVoixn7M_VLcHPLv4C7-AykF9TqMfugaCiYQx1Dz8oPPgpwmITR1rxeTN2ww2cU9s1CfRDBD_AIfVd6KYVHPu-97-fiJNuDT7A6UAEiyncUNgcwBzO67G5pRaqOhKvfOrwPSzGqd18YDuu7iPtP889dn18dFWd8LOLb9-r-RlvslyP3Em1zKUjV5qirJdKL5vGONSyIVKEJt1bQeioKITSDuscVaZKlFqbttUu22Oft7nr4O8niqO981MYUqWVRsoMswJ1ouSWaoKPMZCz69Ct6rCxAu2TfrvVb5N--1e_Fenp03P0tFxR-_Lyz3cCsi0Q02lITl67_xP7CAEvkNc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2622303805</pqid></control><display><type>article</type><title>The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study</title><source>MEDLINE</source><source>Springer Online Journals Complete</source><creator>Kassie, Gizat M. ; Roughead, Elizabeth E. ; Nguyen, Tuan A. ; Pratt, Nicole L. ; Kalisch Ellett, Lisa M.</creator><creatorcontrib>Kassie, Gizat M. ; Roughead, Elizabeth E. ; Nguyen, Tuan A. ; Pratt, Nicole L. ; Kalisch Ellett, Lisa M.</creatorcontrib><description>Introduction
Medicines acting on the central nervous system can increase the risk of postoperative delirium, but the specific medicines associated with greatest risk remain unclear.
Objectives
We aimed to examine the risk of individual central nervous system-acting medicines used preoperatively on delirium after hip or knee surgery.
Methods
A matched case-control study was conducted using data from the Australian Government Department of Veterans’ Affairs. We included people aged 65 years or older who had knee or hip surgery between 2000 and 2019. People with hip or knee surgery who developed postoperative delirium were cases and controls were people with hip or knee surgery but who did not develop postoperative delirium. Use of medicines including anxiolytics, sedatives, and hypnotics, opioid analgesics and antidepressants prior to surgery was compared between cases and controls.
Results
A total of 2614 patient cases with postoperative delirium were matched by same sex, age (±2 years), and year of admission (±2 years) with 7842 controls without postoperative delirium. Cases were more likely to be exposed to nitrazepam (odds ratio [OR] = 1.81, 95% confidence interval [CI] 1.24–2.64), sertraline (OR = 1.50, 95% CI 1.20–1.87), mirtazapine (OR = 1.38, 95% CI 1.11–1.74), venlafaxine (OR = 1.42, 95% CI 1.02–1.98), citalopram (OR = 1.54, 95% CI 1.19–1.99), escitalopram (OR = 1.42, 95% CI 1.06–1.89) or fluvoxamine (OR = 5.01, 95% CI 2.15–11.68) prior to surgery than controls. At the class level, exposure to benzodiazepines (OR = 1.20, 95% CI 1.05–1.37) and antidepressants (OR = 1.64, 95% CI 1.47–1.83) prior to surgery was significantly higher in cases than in controls. The numbers needed to treat to harm for one additional delirium case were 43 for sertraline, 40 for citalopram, 57 for mirtazapine and 26 for nitrazepam. Whereas, the numbers needed to treat to harm were found to be 20 for sertraline, 17 for citalopram, 19 for mirtazapine and 10 for nitrazepam in the 85 years or older age group, indicating that the harmful effect of these medicines is pronounced as age advances.
Conclusions
People who developed delirium following hip or knee surgery were more likely to be exposed to nitrazepam, sertraline, mirtazapine, venlafaxine, citalopram, escitalopram or fluvoxamine at the time of admission for surgery. Planning to reduce use of these medicines well prior to surgery may decrease the risk of postoperative delirium.</description><identifier>ISSN: 0114-5916</identifier><identifier>EISSN: 1179-1942</identifier><identifier>DOI: 10.1007/s40264-021-01136-1</identifier><identifier>PMID: 34748199</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Age ; Aged ; Analgesics ; Antidepressants ; Antidepressive Agents - adverse effects ; Anxiolytics ; Australia - epidemiology ; Benzodiazepines ; Case-Control Studies ; Central Nervous System ; Citalopram ; Codes ; Confidence intervals ; Delirium ; Delirium - chemically induced ; Delirium - epidemiology ; Dementia ; Drug Safety and Pharmacovigilance ; Ethics ; Exposure ; Fluvoxamine ; Fractures ; Hip ; Hospitalization ; Hospitals ; Humans ; Hypnotics ; Joint surgery ; Knee ; Medicine ; Medicine & Public Health ; Mental disorders ; Mirtazapine ; Mortality ; Narcotics ; Nervous system ; Nitrazepam ; Older people ; Opioids ; Original Research Article ; Patients ; Pharmacology/Toxicology ; Population ; Psychotropic drugs ; Risk ; Risk Factors ; Sedatives ; Sertraline ; Socioeconomic factors ; Surgery ; Systematic review ; Venlafaxine ; Venlafaxine Hydrochloride</subject><ispartof>Drug safety, 2022, Vol.45 (1), p.75-82</ispartof><rights>Crown 2021</rights><rights>2021. Crown.</rights><rights>Copyright Springer Nature B.V. Jan 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-f24b72fef9689ab45bcc6f052cee4e06f24d1e0fe88145f0a70434902556dd5f3</citedby><cites>FETCH-LOGICAL-c375t-f24b72fef9689ab45bcc6f052cee4e06f24d1e0fe88145f0a70434902556dd5f3</cites><orcidid>0000-0003-4286-3771</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s40264-021-01136-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s40264-021-01136-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34748199$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kassie, Gizat M.</creatorcontrib><creatorcontrib>Roughead, Elizabeth E.</creatorcontrib><creatorcontrib>Nguyen, Tuan A.</creatorcontrib><creatorcontrib>Pratt, Nicole L.</creatorcontrib><creatorcontrib>Kalisch Ellett, Lisa M.</creatorcontrib><title>The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study</title><title>Drug safety</title><addtitle>Drug Saf</addtitle><addtitle>Drug Saf</addtitle><description>Introduction
Medicines acting on the central nervous system can increase the risk of postoperative delirium, but the specific medicines associated with greatest risk remain unclear.
Objectives
We aimed to examine the risk of individual central nervous system-acting medicines used preoperatively on delirium after hip or knee surgery.
Methods
A matched case-control study was conducted using data from the Australian Government Department of Veterans’ Affairs. We included people aged 65 years or older who had knee or hip surgery between 2000 and 2019. People with hip or knee surgery who developed postoperative delirium were cases and controls were people with hip or knee surgery but who did not develop postoperative delirium. Use of medicines including anxiolytics, sedatives, and hypnotics, opioid analgesics and antidepressants prior to surgery was compared between cases and controls.
Results
A total of 2614 patient cases with postoperative delirium were matched by same sex, age (±2 years), and year of admission (±2 years) with 7842 controls without postoperative delirium. Cases were more likely to be exposed to nitrazepam (odds ratio [OR] = 1.81, 95% confidence interval [CI] 1.24–2.64), sertraline (OR = 1.50, 95% CI 1.20–1.87), mirtazapine (OR = 1.38, 95% CI 1.11–1.74), venlafaxine (OR = 1.42, 95% CI 1.02–1.98), citalopram (OR = 1.54, 95% CI 1.19–1.99), escitalopram (OR = 1.42, 95% CI 1.06–1.89) or fluvoxamine (OR = 5.01, 95% CI 2.15–11.68) prior to surgery than controls. At the class level, exposure to benzodiazepines (OR = 1.20, 95% CI 1.05–1.37) and antidepressants (OR = 1.64, 95% CI 1.47–1.83) prior to surgery was significantly higher in cases than in controls. The numbers needed to treat to harm for one additional delirium case were 43 for sertraline, 40 for citalopram, 57 for mirtazapine and 26 for nitrazepam. Whereas, the numbers needed to treat to harm were found to be 20 for sertraline, 17 for citalopram, 19 for mirtazapine and 10 for nitrazepam in the 85 years or older age group, indicating that the harmful effect of these medicines is pronounced as age advances.
Conclusions
People who developed delirium following hip or knee surgery were more likely to be exposed to nitrazepam, sertraline, mirtazapine, venlafaxine, citalopram, escitalopram or fluvoxamine at the time of admission for surgery. Planning to reduce use of these medicines well prior to surgery may decrease the risk of postoperative delirium.</description><subject>Age</subject><subject>Aged</subject><subject>Analgesics</subject><subject>Antidepressants</subject><subject>Antidepressive Agents - adverse effects</subject><subject>Anxiolytics</subject><subject>Australia - epidemiology</subject><subject>Benzodiazepines</subject><subject>Case-Control Studies</subject><subject>Central Nervous System</subject><subject>Citalopram</subject><subject>Codes</subject><subject>Confidence intervals</subject><subject>Delirium</subject><subject>Delirium - chemically induced</subject><subject>Delirium - epidemiology</subject><subject>Dementia</subject><subject>Drug Safety and Pharmacovigilance</subject><subject>Ethics</subject><subject>Exposure</subject><subject>Fluvoxamine</subject><subject>Fractures</subject><subject>Hip</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypnotics</subject><subject>Joint surgery</subject><subject>Knee</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Mental disorders</subject><subject>Mirtazapine</subject><subject>Mortality</subject><subject>Narcotics</subject><subject>Nervous system</subject><subject>Nitrazepam</subject><subject>Older people</subject><subject>Opioids</subject><subject>Original Research Article</subject><subject>Patients</subject><subject>Pharmacology/Toxicology</subject><subject>Population</subject><subject>Psychotropic drugs</subject><subject>Risk</subject><subject>Risk Factors</subject><subject>Sedatives</subject><subject>Sertraline</subject><subject>Socioeconomic factors</subject><subject>Surgery</subject><subject>Systematic review</subject><subject>Venlafaxine</subject><subject>Venlafaxine Hydrochloride</subject><issn>0114-5916</issn><issn>1179-1942</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kMFO3DAQhq2qqGwpL9BDNVLPbseO7STcVgFKBRTUhbOVTcYQmo0XO6HaV-hTY7oUbj2NNPPN_0sfYx8FfhGI-deoUBrFUQqOQmSGizdsJkReclEq-ZbN0lZxXQqzy97HeIeIhTTFO7abqVwVoixn7M_VLcHPLv4C7-AykF9TqMfugaCiYQx1Dz8oPPgpwmITR1rxeTN2ww2cU9s1CfRDBD_AIfVd6KYVHPu-97-fiJNuDT7A6UAEiyncUNgcwBzO67G5pRaqOhKvfOrwPSzGqd18YDuu7iPtP889dn18dFWd8LOLb9-r-RlvslyP3Em1zKUjV5qirJdKL5vGONSyIVKEJt1bQeioKITSDuscVaZKlFqbttUu22Oft7nr4O8niqO981MYUqWVRsoMswJ1ouSWaoKPMZCz69Ct6rCxAu2TfrvVb5N--1e_Fenp03P0tFxR-_Lyz3cCsi0Q02lITl67_xP7CAEvkNc</recordid><startdate>2022</startdate><enddate>2022</enddate><creator>Kassie, Gizat M.</creator><creator>Roughead, Elizabeth E.</creator><creator>Nguyen, Tuan A.</creator><creator>Pratt, Nicole L.</creator><creator>Kalisch Ellett, Lisa M.</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>4T-</scope><scope>7RV</scope><scope>7T2</scope><scope>7TK</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><orcidid>https://orcid.org/0000-0003-4286-3771</orcidid></search><sort><creationdate>2022</creationdate><title>The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study</title><author>Kassie, Gizat M. ; Roughead, Elizabeth E. ; Nguyen, Tuan A. ; Pratt, Nicole L. ; Kalisch Ellett, Lisa M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-f24b72fef9689ab45bcc6f052cee4e06f24d1e0fe88145f0a70434902556dd5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Age</topic><topic>Aged</topic><topic>Analgesics</topic><topic>Antidepressants</topic><topic>Antidepressive Agents - adverse effects</topic><topic>Anxiolytics</topic><topic>Australia - epidemiology</topic><topic>Benzodiazepines</topic><topic>Case-Control Studies</topic><topic>Central Nervous System</topic><topic>Citalopram</topic><topic>Codes</topic><topic>Confidence intervals</topic><topic>Delirium</topic><topic>Delirium - chemically induced</topic><topic>Delirium - epidemiology</topic><topic>Dementia</topic><topic>Drug Safety and Pharmacovigilance</topic><topic>Ethics</topic><topic>Exposure</topic><topic>Fluvoxamine</topic><topic>Fractures</topic><topic>Hip</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypnotics</topic><topic>Joint surgery</topic><topic>Knee</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Mental disorders</topic><topic>Mirtazapine</topic><topic>Mortality</topic><topic>Narcotics</topic><topic>Nervous system</topic><topic>Nitrazepam</topic><topic>Older people</topic><topic>Opioids</topic><topic>Original Research Article</topic><topic>Patients</topic><topic>Pharmacology/Toxicology</topic><topic>Population</topic><topic>Psychotropic drugs</topic><topic>Risk</topic><topic>Risk Factors</topic><topic>Sedatives</topic><topic>Sertraline</topic><topic>Socioeconomic factors</topic><topic>Surgery</topic><topic>Systematic review</topic><topic>Venlafaxine</topic><topic>Venlafaxine Hydrochloride</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kassie, Gizat M.</creatorcontrib><creatorcontrib>Roughead, Elizabeth E.</creatorcontrib><creatorcontrib>Nguyen, Tuan A.</creatorcontrib><creatorcontrib>Pratt, Nicole L.</creatorcontrib><creatorcontrib>Kalisch Ellett, Lisa M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Docstoc</collection><collection>Nursing & Allied Health Database</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><jtitle>Drug safety</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kassie, Gizat M.</au><au>Roughead, Elizabeth E.</au><au>Nguyen, Tuan A.</au><au>Pratt, Nicole L.</au><au>Kalisch Ellett, Lisa M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study</atitle><jtitle>Drug safety</jtitle><stitle>Drug Saf</stitle><addtitle>Drug Saf</addtitle><date>2022</date><risdate>2022</risdate><volume>45</volume><issue>1</issue><spage>75</spage><epage>82</epage><pages>75-82</pages><issn>0114-5916</issn><eissn>1179-1942</eissn><abstract>Introduction
Medicines acting on the central nervous system can increase the risk of postoperative delirium, but the specific medicines associated with greatest risk remain unclear.
Objectives
We aimed to examine the risk of individual central nervous system-acting medicines used preoperatively on delirium after hip or knee surgery.
Methods
A matched case-control study was conducted using data from the Australian Government Department of Veterans’ Affairs. We included people aged 65 years or older who had knee or hip surgery between 2000 and 2019. People with hip or knee surgery who developed postoperative delirium were cases and controls were people with hip or knee surgery but who did not develop postoperative delirium. Use of medicines including anxiolytics, sedatives, and hypnotics, opioid analgesics and antidepressants prior to surgery was compared between cases and controls.
Results
A total of 2614 patient cases with postoperative delirium were matched by same sex, age (±2 years), and year of admission (±2 years) with 7842 controls without postoperative delirium. Cases were more likely to be exposed to nitrazepam (odds ratio [OR] = 1.81, 95% confidence interval [CI] 1.24–2.64), sertraline (OR = 1.50, 95% CI 1.20–1.87), mirtazapine (OR = 1.38, 95% CI 1.11–1.74), venlafaxine (OR = 1.42, 95% CI 1.02–1.98), citalopram (OR = 1.54, 95% CI 1.19–1.99), escitalopram (OR = 1.42, 95% CI 1.06–1.89) or fluvoxamine (OR = 5.01, 95% CI 2.15–11.68) prior to surgery than controls. At the class level, exposure to benzodiazepines (OR = 1.20, 95% CI 1.05–1.37) and antidepressants (OR = 1.64, 95% CI 1.47–1.83) prior to surgery was significantly higher in cases than in controls. The numbers needed to treat to harm for one additional delirium case were 43 for sertraline, 40 for citalopram, 57 for mirtazapine and 26 for nitrazepam. Whereas, the numbers needed to treat to harm were found to be 20 for sertraline, 17 for citalopram, 19 for mirtazapine and 10 for nitrazepam in the 85 years or older age group, indicating that the harmful effect of these medicines is pronounced as age advances.
Conclusions
People who developed delirium following hip or knee surgery were more likely to be exposed to nitrazepam, sertraline, mirtazapine, venlafaxine, citalopram, escitalopram or fluvoxamine at the time of admission for surgery. Planning to reduce use of these medicines well prior to surgery may decrease the risk of postoperative delirium.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>34748199</pmid><doi>10.1007/s40264-021-01136-1</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0003-4286-3771</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0114-5916 |
ispartof | Drug safety, 2022, Vol.45 (1), p.75-82 |
issn | 0114-5916 1179-1942 |
language | eng |
recordid | cdi_proquest_journals_2622303805 |
source | MEDLINE; Springer Online Journals Complete |
subjects | Age Aged Analgesics Antidepressants Antidepressive Agents - adverse effects Anxiolytics Australia - epidemiology Benzodiazepines Case-Control Studies Central Nervous System Citalopram Codes Confidence intervals Delirium Delirium - chemically induced Delirium - epidemiology Dementia Drug Safety and Pharmacovigilance Ethics Exposure Fluvoxamine Fractures Hip Hospitalization Hospitals Humans Hypnotics Joint surgery Knee Medicine Medicine & Public Health Mental disorders Mirtazapine Mortality Narcotics Nervous system Nitrazepam Older people Opioids Original Research Article Patients Pharmacology/Toxicology Population Psychotropic drugs Risk Risk Factors Sedatives Sertraline Socioeconomic factors Surgery Systematic review Venlafaxine Venlafaxine Hydrochloride |
title | The Risk of Preoperative Central Nervous System-Acting Medications on Delirium Following Hip or Knee Surgery: A Matched Case-Control Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T15%3A36%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Risk%20of%20Preoperative%20Central%20Nervous%20System-Acting%20Medications%20on%20Delirium%20Following%20Hip%20or%20Knee%20Surgery:%20A%20Matched%20Case-Control%20Study&rft.jtitle=Drug%20safety&rft.au=Kassie,%20Gizat%20M.&rft.date=2022&rft.volume=45&rft.issue=1&rft.spage=75&rft.epage=82&rft.pages=75-82&rft.issn=0114-5916&rft.eissn=1179-1942&rft_id=info:doi/10.1007/s40264-021-01136-1&rft_dat=%3Cproquest_cross%3E2622303805%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2622303805&rft_id=info:pmid/34748199&rfr_iscdi=true |